← Back to Search

Dietary Supplement

Dietary Protein Shake for Dietary Proteins (mTOR Trial)

N/A
Waitlist Available
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 hour, 1 hour and 3 hours
Awards & highlights

mTOR Trial Summary

This trial will help determine if high protein low carbohydrate diets are associated with an increased risk of cardiovascular disease.

mTOR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 hour, 1 hour and 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 hour, 1 hour and 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determination of amino acid levels and mTOR activation in circulating monocytes isolated from subjects ingesting high vs low protein drinks.
Secondary outcome measures
Determination of changes in autophagy and apoptosis markers in circulating monocytes over time after ingestion of a protein shake
Determination of changes in inflammatory markers in circulating monocytes over time after ingestion of a protein shake.
Determination of changes in reactive oxygen species in circulating monocytes over time after ingestion of a protein shake.

mTOR Trial Design

2Treatment groups
Active Control
Group I: High proteinActive Control1 Intervention
Subjects getting high protein shake
Group II: Low proteinActive Control1 Intervention
Subjects getting low protein shake

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,853 Total Patients Enrolled

Media Library

Dietary protein shake (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03946774 — N/A
Dietary Proteins Research Study Groups: High protein, Low protein
Dietary Proteins Clinical Trial 2023: Dietary protein shake Highlights & Side Effects. Trial Name: NCT03946774 — N/A
Dietary protein shake (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03946774 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling
2019. "Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03946774.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top